---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-061365"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-03-07T23:59:59+00:00"
generated_at: "2026-06-05T01:47:50.893774+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoodRx repurchases 20.9M shares from Spectrum, Francisco Partners at $7.19, discount to $7.57 close

## Summary
- Repurchases 6,239,942 shares from Spectrum and 14,622,366 from Francisco Partners, total 20,862,308 shares.
- Price of $7.19 per share is 5% discount to $7.57 closing price on March 6, 2024.
- Total cost approximately $150M; about $299.6M remains under existing $450M buyback program.
- Spectrum and Francisco Partners agree not to trade shares until after Q1 2024 earnings release.
- Closing expected on or about March 11, 2024, subject to customary conditions.

## SEC filing metadata
- accession: 0001193125-24-061365
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000119312524061365/0001193125-24-061365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000119312524061365/d766183d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-061365
- JSON: https://secwatch.observer/filing/0001193125-24-061365.json
- Plain text: https://secwatch.observer/filing/0001193125-24-061365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
